Valuation Vineet Laboratories Limited

Stocks

Delayed NSE India S.E. 09:40:27 29/10/2026 +04			5-day change	1st Jan Change
36.97 ^INR	+2.52%		-0.59%	+0.52%

10-27	Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-25	Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025
Market Cap ¹	439.3	381.7	446.2	287.6
Change	-	-13.12%	16.91%	-35.54%
Enterprise Value (EV) ¹	523.3	686.2	886.9	685
Change	-	31.15%	29.24%	-22.76%
P/E	6.62x	30.5x	43.6x	-1.42x
PBR	1.32x	1.13x	1.28x	1.96x
PEG	0x	-0.4x	-2.4x	0x
Capitalization / Revenue	229,785x	179,783x	295,567x	373,778x
EV / Revenue	-	-	-	-
EV / EBITDA	-	-	-	-
EV / EBIT	4.66x	12.2x	17.5x	-4.07x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ²	1	-	-	-
Rate of return	2.1%	-	-	-
EPS ²	7.201	1.359	1.11	-21.9
Distribution rate	13.9%	-	-	-
Net sales	1,912	2,123	1,510	769.5
EBITDA	132.4	79.97	74.27	-143.3
EBIT ¹	112.3	56.24	50.54	-168.3
Net income ¹	66.39	12.52	10.27	-201.9
Net Debt ¹	83.97	304.6	440.7	397.4
Reference price ²	47.65	41.40	48.40	31.20
Nbr of stocks (in thousands)	9,219	9,219	9,219	9,219
Announcement Date	05/09/22	05/09/23	04/09/24	02/09/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VINEET LABORATORIES LIMITED	-	-	-	-	7.27M
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,148B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	652B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	505B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	348B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	294B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	264B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	244B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	29.58x	7.09x	18.77x	2.12%	403.72B
Weighted average by Cap.	35.24x	8.36x	20.49x	1.8%